New website will host information on Twitter’s new privacy products and announcements Twitter is also looking to change its current data protection and privacy terms Twitter has recently launched a new website called Twit....

  Trump administration had issued 75 licenses to allow Huawei suppliers to resume sales U.S. Commerce Department and other authorities focused on utilizing De minimis Rule The U.S. government is reportedly considering new policie....

Rajasthan Electronics & Instruments Ltd, a state-owned prominent leader in electronics industry and Energy Efficiency Services Ltd, a joint venture of state-owned NTPC LTD, POWERGRID, Power Finance Corp., and Rural Electrification Corp.....

Japan’s research-based pharma company, Chugai Pharmaceutical Co., Ltd. has recently made it to headlines when it agreed to change the equity structure of C&C Research Laboratories (C&C), a Korean joint venture w....

Clover Biopharmaceuticals, a renowned research-based, clinical-stage biotechnology firm, reportedly announced that it has closed a $43 million Series B investment round. The investment round was led by Lapam Capital and Delos Capital, with....

Cinda Biopharmaceutical, a startup that focuses on treating autoimmune and metabolic diseases, has recently announced the completion of its Phase I clinical study of human epidermal growth factor receptor-2 (HER2) and antibodies against pro....

TFF Pharmaceuticals, Inc., claims that it has initiated Voriconazole Inhalation Powder’s phase 1 clinical trial —Voriconazole’s inhaled dry powder version that is direct-to-lung and complements next-generation version. Whe....

  The company’s drug candidate DNX-2401 in combination with Pembrolizumab depicted clinical benefit in brain tumors like Recurrent Glioblastoma.   Study data showed interim median overall survival duration of more than ....

Clinical-stage immunotherapy firm Harpoon Therapeutics & biopharma company AbbVie Inc have reportedly announced a collaboration to obtain a global license for HPN217. HPN217 is a BCMA (B cell maturation antigen) - targeting Tri-specific....

QIAGEN N.V., a leader in molecular diagnostics and pharmaceutical research, recently revealed a new agreement with North Carolina based LabCorp® to extend its Clinical Insights (QCI) license with its Human Gene Mutation Database (HGMD).....